Related Experiment Videos

Clinical differentiation of atypical pneumonia using Japanese guidelines

Tadashi Ishida1, Naoyuki Miyashita, Chikara Nakahama

  • 1Department of Respiratory Medicine, Kurashiki Central Hospital, Miwa, Japan. ishidat@kchnet.or.jp

Respirology (Carlton, Vic.)
|January 9, 2007
PubMed
Abstract

Insights

Japanese Respiratory Society guidelines can help differentiate atypical pneumonia from bacterial pneumonia based on clinical symptoms and lab findings. This is crucial for effective treatment, especially in Japan due to high macrolide resistance.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Atypical pneumonia is a significant cause of community-acquired pneumonia.
  • Accurate diagnosis is essential for appropriate treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of Japanese Respiratory Society guidelines in diagnosing atypical pneumonia.
  • To determine if clinical and laboratory criteria can differentiate atypical pneumonia.

Main Methods:

  • Analysis of data from three prospective studies involving 285 patients with atypical pneumonia and 515 with bacterial pneumonia.
  • Assessment of six diagnostic criteria for atypical pneumonia, including age, underlying diseases, cough, auscultatory findings, sputum/etiological agent, and white blood cell count.

Main Results:

  • All diagnostic criteria were valid except for age in Chlamydophila pneumoniae pneumonia.
  • Sensitivity and specificity for atypical pneumonia diagnosis were 77.0% and 93.0% using four or more criteria.
  • Clinical symptoms and laboratory findings showed moderate ability to differentiate pure atypical pneumonia.

Conclusions:

  • The Japanese Respiratory Society guidelines provide a useful framework for differentiating atypical pneumonia.
  • Distinguishing between bacterial and atypical pneumonia is critical in regions with high Streptococcus pneumoniae macrolide resistance.
  • Empirical treatment covering both pneumonia types is recommended for elderly patients and those with respiratory conditions.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.